Liqing Kang
Standard Bio (Norway)(NO)Shanghai Genon Biological Products (China)(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects, Lymphoma Diagnosis and Treatment, Advancements in Semiconductor Devices and Circuit Design
Most-Cited Works
- → CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation(2021)117 cited
- → Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden(2019)91 cited
- → Anti‐CD19 and anti‐BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem‐cell transplantation for high‐risk newly diagnosed multiple myeloma(2022)73 cited
- → Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes(2020)72 cited
- → Nanoengineered Neutrophils as a Cellular Sonosensitizer for Visual Sonodynamic Therapy of Malignant Tumors(2022)69 cited
- → pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis(2017)62 cited
- → Tandom Autologous Transplantation and Combined Infusion of CD19 and Bcma-Specific Chimeric Antigen Receptor T Cells for High Risk MM: Initial Safety and Efficacy Report from a Clinical Pilot Study(2018)59 cited
- → Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma(2020)49 cited
- → Cholesterol Esterification Enzyme Inhibition Enhances Antitumor Effects of Human Chimeric Antigen Receptors Modified T Cells(2017)45 cited
- → Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma(2020)42 cited